Fundraising Fox

Andy Morley

Investor

Principal at O2h Ventures

Congleton, England, United Kingdom

About

A medicinal chemist with over 25 years in major pharma (Sanofi-Aventis, AstraZeneca) who leads scientific evaluation of investments at o2h Ventures. He is an inventor on 55+ publications and patents and serves as CSO of Opal Oncology.

Experience

  1. o2h venturesChief Scientific Officercurrent2014 — present
  2. o2h groupChief Scientific Officercurrent2014 — present
  3. Opal Oncology LimitedCSOcurrent2012 — presentCambridge, United Kingdom
  4. Andy Morley LTD3D Fragment Library Project Manager and Medicinal Chemistry Consultant2011 — 2013Cheshire
  5. AstraZenecaPrincipal Scientist Medicinal Chemistry2007 — 2011
  6. AstraZenecaTeam Leader, Medicinal Chemistry2000 — 2007
  7. AventisSection Manager1999 — 2000
  8. Rhone-Poulenc RorerSenior Research Fellow1998 — 1999
  9. Rhone-Poulenc RorerSenior Research Scientist1992 — 1998

Education

  1. Nagoya UniversityPost Doc, Asymmetric Hydrogenation1990 — 1991
  2. The University of SalfordPh D, Acyl-nitroso cycloadditions1987 — 1990
  3. Nagoya University

Skills & more

GPCRs24Kinases11Lead Optimisation6Competitive Intelligence2Lead Generation4Project Generation1Medicinal Chemistry64Drug Discovery75Lead Change18Organic Synthesis16ADME9Organic Chemistry23
+12 morePharmaceutical ResearchProject ManagementOutsourcingDrug DesignHeterocyclic ChemistryHPLCParallel SynthesisChemistryPharmaceutical IndustryInflammationDMPKLifesciences

Languages French · Japanese (elementary)

From Andy's professional profile.

Colleagues at O2h Ventures

Frequently asked questions

Where does Andy Morley work?
Andy Morley is Principal at O2h Ventures.

Same school

Shared employers